RELAPSED/REFRACTORY

Clinical trials for RELAPSED/REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Promising leukemia combo study pulled before starting

Disease control Terminated

This study aimed to find safe doses of two experimental drugs (lisaftoclax and pelcitoclax) combined with standard FLAG chemotherapy for adults with T-cell acute lymphoblastic leukemia that returned or didn't respond to treatment. The trial was withdrawn before enrolling any part…

Matched conditions: RELAPSED/REFRACTORY

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

RELAPSED/REFRACTORY

Get alerted when new RELAPSED/REFRACTORY trials appear

Promising leukemia combo study pulled before starting